Results 211 to 220 of about 475,040 (341)

Rice‐derived SARS‐CoV‐2 glycoprotein S1 subunit vaccine elicits humoral and cellular immune responses

Plant Biotechnology Journal, EarlyView.
Summary Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus causing COVID‐19, has been spreading and mutating globally despite the expedited approval of many commercial vaccines. Therefore, developing safe, effective and affordable vaccines remains essential to meet the global demand, particularly in developing countries.
Li Song, Yaya Wen, Yu Zhou, Hui Zhang, Yuqi Tian, Jing Wang, Yaodan Cui, Ruimeng Tan, Dan Xiong, Chuang Meng, Yan Zhou, Qianfeng Li, Zhiming Pan, Qiaoquan Liu, Xinan Jiao   +14 more
wiley   +1 more source

A public health call for action to address liver cancer and hepatitis in northern Ghana. [PDF]

Commun Med (Lond)
Tuck C, Timtoni Iddrisu AR, Moro SA, Akparibo R, Aryeetey R, Gray L, Cooper R.   +6 more
europepmc   +1 more source

Production of monoclonal antibodies to hepatitis B surface and core antigens, and use in the detection of viral antigens in liver biopsies [PDF]

, 1983
Richard S. Tedder, P. Guarascio, J. L. Yao, R. Bridget Lord, A L Eddleston   +4 more
openalex   +1 more source

Kidney Injury Molecule‐1 Expression in Pathological T1b Clear Cell Renal Cell Carcinoma: A Putative Biomarker of High Immune‐Inflamed Status and Recurrence

Pathology International, EarlyView.
High membranous kidney injury molecule‐1 (KIM‐1) expression in pathological T1b (pT1b) clear cell renal cell carcinoma (ccRCC) was significantly associated with a higher nuclear grade, tumor necrosis, hot tumor associated immune cell (TAIC) status, and shorter recurrence‐free survival (RFS) and cancer‐specific survival, and was an independent predictor
Ayuna Sugai, Kosuke Miyai, Keiichi Ito, Susumu Matsukuma, Kimiya Sato   +4 more
wiley   +1 more source

Hepatitis surface B antigen clearance induced by long-term tenofovir disoproxil fumarate monotherapy in chronic hepatitis B treatment: a meta-analysis and longitudinal modeling analysis. [PDF]

Virol J
Jian W, Yin Y, Xue J, Chen R, Feng J, Zeng J, He R, Zhou T.   +7 more
europepmc   +1 more source

Risk of Cytomegalovirus Viremia Following Transplantation of Hepatitis C‐Viremic Donor Kidneys Into Uninfected Recipients: A Multi‐Center Retrospective Cohort Study

Transplant Infectious Disease, EarlyView.
The risk of CMV viremia was not significantly increased among HCV D+/R− kidney recipients. Future studies should examine associations between donor‐derived HCV infection and clinical outcomes of CMV syndrome and disease. ABSTRACT Background Several studies have suggested an increased risk of cytomegalovirus (CMV) viremia among Hepatitis C virus (HCV ...
Vishnu S. Potluri, David Goldberg, Siqi Zhang, Douglas E. Schaubel, Miklos Z. Molnar, Rachel Forbes, Megan E. Sise, James L. Rogers, Vasanthi Balaraman, Anshul Bhalla, David Shaffer, Beatrice P. Concepcion, Raymond T. Chung, Ian A. Strohbehn, Shristi Mapchan, Vikas Vujjini, Akhila Sangadi, Eric Martin, Roy D. Bloom, Alyssa Ammazzalorso, Emily A. Blumberg, Peter P. Reese   +21 more
wiley   +1 more source

Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin.

, 1984
Marie‐Louise Michel, Patrizia Pontisso, Eliane Sobczak, Y. Malpièce, Rolf E. Streeck, Pierre Tiollais   +5 more
openalex   +1 more source

Evaluation of Discrepant Infectious Disease Results in Deceased Organ Donors: Insights from a Retrospective Analysis of Post‐Policy Testing

Transplant Infectious Disease, EarlyView.
Organ Procurement Transplant Network Policy 2.9.2 requires repeat testing of deceased donors if the donation has not proceeded within 96‐h after the infectious disease screening was initially performed. This study reviews result discrepancies (1.69% discrepancy rate), explores investigations behind peculiar results, and offers several recommendations ...
Sara Dionne, Hillary Akana, Chris Curran, Sean Van Slyck   +3 more
wiley   +1 more source

A Data-Driven Approach to Assessing Hepatitis B Mother-to-Child Transmission Risk Prediction Model: Machine Learning Perspective. [PDF]

JMIR Form Res
Nguyen Tien D, Thi Thu Bui H, Hoang Thi Ngoc T, Thi Pham T, Trung Nguyen D, Nguyen Thi Thu H, Thu Hang Vu T, Lan Anh Luong T, Thu Hoang L, Cam Tu H, Körber N, Bauer T, Khanh Ho L.   +12 more
europepmc   +1 more source

Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice.

, 1987
Hend Farza, A.-M. Salmon, Michelle Hadchouel, Jean‐Luc Moreau, Charles Babinet, Pierre Tiollais, Christine Pourcel   +6 more
openalex   +1 more source